PortfoliosLab logoPortfoliosLab logo
FGM vs. CORT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FGM vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Germany AlphaDEX Fund (FGM) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FGM achieves a 3.19% return, which is significantly lower than CORT's 138.25% return. Over the past 10 years, FGM has underperformed CORT with an annualized return of 8.76%, while CORT has yielded a comparatively higher 31.68% annualized return.


FGM

1D
1.21%
1M
-2.27%
YTD
3.19%
6M
4.60%
1Y
17.41%
3Y*
20.38%
5Y*
4.13%
10Y*
8.76%

CORT

1D
-0.41%
1M
45.25%
YTD
138.25%
6M
-5.77%
1Y
16.48%
3Y*
52.65%
5Y*
30.95%
10Y*
31.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FGM vs. CORT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FGM
First Trust Germany AlphaDEX Fund
3.19%63.60%1.36%13.28%-30.46%6.10%17.26%20.77%-25.14%44.28%
CORT
Corcept Therapeutics Incorporated
138.25%-30.94%55.14%59.92%2.58%-24.31%116.20%-9.43%-26.02%148.76%

Correlation

The correlation between FGM and CORT is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Feb 17, 2012

0.21

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FGM vs. CORT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FGM
FGM Risk / Return Rank: 2525
Overall Rank
FGM Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
FGM Sortino Ratio Rank: 2626
Sortino Ratio Rank
FGM Omega Ratio Rank: 2525
Omega Ratio Rank
FGM Calmar Ratio Rank: 2424
Calmar Ratio Rank
FGM Martin Ratio Rank: 2525
Martin Ratio Rank

CORT
CORT Risk / Return Rank: 5353
Overall Rank
CORT Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
CORT Sortino Ratio Rank: 5252
Sortino Ratio Rank
CORT Omega Ratio Rank: 6363
Omega Ratio Rank
CORT Calmar Ratio Rank: 4949
Calmar Ratio Rank
CORT Martin Ratio Rank: 4949
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FGM vs. CORT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Germany AlphaDEX Fund (FGM) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FGMCORTDifference
Sharpe ratioReturn per unit of total volatility

+0.62

Sortino ratioReturn per unit of downside risk

+0.46

Omega ratioGain probability vs. loss probability

1.16

1.17

-0.01

Calmar ratioReturn relative to maximum drawdown

0.98

0.26

+0.73

Martin ratioReturn relative to average drawdown

3.01

0.47

+2.54

FGM vs. CORT - Sharpe Ratio Comparison

The current FGM Sharpe Ratio is 0.84, which is higher than the CORT Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of FGM and CORT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FGM vs. CORT - Drawdown Comparison

The maximum FGM drawdown since its inception was -51.58%, smaller than the maximum CORT drawdown of -94.29%. Use the drawdown chart below to compare losses from any high point for FGM and CORT.


Loading charts...

Drawdown Indicators


FGMCORTDifference

Max Drawdown

Largest peak-to-trough decline

-51.58%

-94.29%

+42.71%

Max Drawdown (1Y)

Largest decline over 1 year

-17.76%

-64.40%

+46.64%

Max Drawdown (3Y)

Largest decline over 3 years

-17.93%

-71.85%

+53.92%

Max Drawdown (5Y)

Largest decline over 5 years

-50.45%

-71.85%

+21.40%

Max Drawdown (10Y)

Largest decline over 10 years

-51.58%

-71.85%

+20.27%

Current Drawdown

Current decline from peak

-8.26%

-27.41%

+19.15%

Average Drawdown

Average peak-to-trough decline

-14.72%

-53.45%

+38.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.81%

35.37%

-29.56%

Volatility

FGM vs. CORT - Volatility Comparison

The current volatility for First Trust Germany AlphaDEX Fund (FGM) is 6.75%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 14.28%. This indicates that FGM experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FGMCORTDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.75%

14.28%

-7.53%

Volatility (6M)

Calculated over the trailing 6-month period

17.55%

85.36%

-67.81%

Volatility (1Y)

Calculated over the trailing 1-year period

20.94%

76.98%

-56.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.54%

74.58%

-50.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.11%

67.23%

-44.12%

Dividends

FGM vs. CORT - Dividend Comparison

FGM's dividend yield for the trailing twelve months is around 0.64%, while CORT has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CORT
Corcept Therapeutics Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FGM
First Trust Germany AlphaDEX Fund
0.64%0.66%2.56%2.82%5.44%1.43%1.33%2.30%2.18%2.11%1.33%1.13%

Frequently Asked Questions


FGM and CORT have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CORT has higher volatility (14.28%) compared to FGM (6.75%). In terms of maximum drawdown, FGM dropped -51.58% vs CORT's -94.29%.

FGM currently has the higher Sharpe Ratio (0.84 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FGM and CORT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer